Related Experiment Video
Updated: Feb 14, 2026

A Label-Free Segmentation Approach for Intravital Imaging of Mammary Tumor Microenvironment
Published on: May 24, 2022
Egr-1 is required for neu/HER2-induced mammary tumors
Sunhwa Oh1, Hyungjoo Kim1, KeeSoo Nam1
1Department of Life Science, Hanyang University, Seoul 04763, Republic of Korea.
Abstract:
Egr-1 is known to function mainly as a tumor suppressor through direct regulation of multiple tumor suppressor genes. To determine the role of Egr-1 in breast tumors in vivo, we used mouse models of breast cancer induced by HER2/neu. We compared neu-overexpressing Egr-1 knockout mice (neu/Egr-1 KO) to neu-overexpressing Egr-1 wild type or heterozygote mice (neu/Egr-1 WT or neu/Egr-1 het) with regard to onset of tumor appearance and number of tumors per mouse. In addition, to examine the role of Egr-1 in vitro, we established neu/Egr-1 WT and KO tumor cell lines derived from breast tumors developed in each mouse. Egr-1 deletion delayed tumor development in vivo and decreased the rate of cell growth in vitro. These results suggest that Egr-1 plays an oncogenic role in HER2/neu-driven mammary tumorigenesis.
Insights
Early growth response-1 (Egr-1) deletion delayed tumor development in HER2/neu-driven breast cancer models. This suggests Egr-1 acts as an oncogene in this specific cancer type.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Early growth response-1 (Egr-1) is typically recognized as a tumor suppressor.
- Its precise role in HER2/neu-driven breast cancer requires further elucidation.
Purpose of the Study:
- To investigate the in vivo and in vitro role of Egr-1 in HER2/neu-induced breast tumorigenesis.
- To determine if Egr-1 acts as a tumor suppressor or oncogene in this context.
Main Methods:
- Utilized mouse models with HER2/neu overexpression and Egr-1 knockout (KO) or wild-type (WT) genotypes.
- Compared tumor onset and multiplicity between neu/Egr-1 KO and neu/Egr-1 WT/heterozygote mice.
- Established and analyzed neu/Egr-1 WT and KO tumor cell lines in vitro.
Main Results:
- Egr-1 deletion significantly delayed tumor development in vivo.
- Egr-1 knockout tumor cell lines exhibited a decreased rate of cell growth in vitro.
- These findings contradict the typical tumor suppressor role of Egr-1 in this model.
Conclusions:
- Egr-1 appears to play an oncogenic role in HER2/neu-driven mammary tumorigenesis.
- Targeting Egr-1 could be a potential therapeutic strategy for HER2/neu-positive breast cancers.
Related Concept Videos
The Mammary Glands
Each breast features a pigmented projection known as the nipple, through which milk emerges via closely spaced openings of ducts, referred to as lactiferous ducts. Surrounding the nipple is a circular pigmented area of skin named the areola, which appears rough due to...
Requirements for Human Life
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...
Proteins: Dietary Sources and Requirements
Oxygen Requirements and Growth Patterns
Carbohydrates: Dietary Sources and Requirements
Lipids: Dietary Sources and Requirements

